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Abstract
This paper proposes a practical yet novel solution to a longstanding
statistical testing problem regarding single subject design. In partic-
ular, we aim to resolve an important clinical question: does a new
patient behave the same as one from a healthy population? This ques-
tion cannot be answered using the traditional single subject design
when only test subject information is used, nor can it be satisfac-
torily resolved by comparing a single-subject’s data with the mean
value of a healthy population without proper assessment of the im-
pact of between and within subject variability. Here, we use Bayesian
posterior predictive draws based on a training set of healthy subjects
to generate a template null distribution of the statistic of interest to
test whether the test subject belongs to the healthy population. This
method also provides an estimate of the error rate associated with
the decision and provides a confidence interval for the point estimate
of interest. Taken together, this information will enable clinicians to
conduct evidence-based clinical decision making by directly comparing
the observed measures with a pre-calculated null distribution for such
measures. Simulation studies show that the proposed test performs
satisfactorily under controlled conditions.
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1 Introduction
Making an inference regarding a single subject is an important goal in clinical
and applied settings and in health and behavioral research (for examples,[1],
[2] and [3]). Here, one is often interested in assessing an individual subject’s
outcome across different behavioral conditions. When only a single data point
is available for each condition, one can only make a visual judgment regard-
ing the direction and magnitude of the change. Kazdin [1] recommended
performing repeated trials under the same condition to reduce the impact
of within subject variability using a repeated measures design such as the
ABAB type, where A and B each refers to different conditions. In this case,
one can perform a within-subject statistical test to evaluate the change using
a randomization based test ([4] and [5]). However the classic single subject
design and method of analysis does not allow clinicians and researchers to
compare the test subject with a reference population and assess the impact
of between subject variability on the decision.
The primary goal of this paper is to demonstrate a method to make an
inference regarding the behavior of any single subject from a group of test
subjects given an available training set of subjects whose status is known.
Instead of making an inference about the average behavior of the test set as
a group, we are interested in assessing the status of test subjects individually
or in small groups and seek to answer questions such as: Does the test subject
behave the same as someone in the healthy population as characterized by the
subjects in the training set? Note that in this setup, the sample size of the
training set may be very small. The training and the test sets both have
repeated measures design, but the number of trials may not be the same.
Moreover the experimental conditions for the test may only be a subset of
the training set.
In this paper we propose a novel statistical framework for testing the
above question in the context of a single subject experiment, given a small
amount of training data. A simple test statistic based on sample mean dif-
ference between conditions for the test subject is compared to a template
distribution as a surrogate for the true sampling distribution of the mean
difference under the null hypothesis. This template distribution is generated
based on Bayesian posterior predictive draws using the training data set and
the single-subject design. In the remainder of the paper, we first introduce
a motivating example from post-stroke hand rehabilitation where a change
in the fingertip grip and load forces and the rate of change are key variables
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for assessing the quality of motor control in a grasping task. We then dis-
cuss several standard statistical models that attempt to answer a research
question in rehabilitation. Next, we outline the proposed method for testing
the performance of a single subject, followed by a simulation study that ex-
amines the proposed method in comparison to more traditional approaches.
The power of hypothesis testing with different single subject designs is also
studied using simulations. Lastly, we analyze a real data set of change in
fingertip forces when grasping and lifting a device in the context of hand re-
habilitation to demonstrate the utility of the method for clinicians and other
practitioners.
2 An Example from Fingertip Force Regulation
An objective assessment of hand function is one of the most sensitive tests
of neurologic dysfunction. Precision grasp is important for a number of daily
activities such as grasping a cup of coffee, or picking up an egg. Johansson et
al. initiated the examination of fingertip force coordination during grasping
[see [6] for a review], and their results have been used as a model to study
sensorimotor integration for more than 30 years. This model has been found
to be effective in detecting impairment of fine motor control in various pa-
tient populations (see for examples, [7][8][9][10][11]). Efficient fingertip force
coordination requires the ability to predict the optimal force when lifting an
object, such as a cup of coffee. In healthy individuals, it has been found that
after just one or two practice lifts, the rate of change of load force is faster for
a heavier object than for a lighter object ([12][13]). Recently, Lu et al. ([14])
showed that after one practice trial, the peak rate of change of load force
increases proportionally as the weight of the object being lifted increases.
However, predictive control of fingertip forces and movements is often
impaired in patients with brain injury due to stroke ([15][16][17]). The as-
sessment and restoration of predictive control of fingertip forces has implica-
tions for diagnosis, prognosis and treatment of neurologic conditions, such as
stroke, multiple sclerosis, Parkinson’s disease, cerebral palsy etc. A specially
constructed device instrumented with force sensors can readily measure the
grip and load forces during a grasp and lift task which involves lifting differ-
ent weights ([14][17] ), and it can be used as a convenient clinical metric to
assess hand performance.
According to Lu et al. ([14]), the logarithm of the peak Load Force Rate
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(PLFR) increases linearly with the object’s weight among healthy subjects
even before the object is lifted (see an illustration in Figure 1). Mathemati-
cally, we can express this as:
log(PLFRi) = αi + βWEIGHTit + it, (1)
where individual i is lifting weight WEIGHTit on trial t, and it is the idiosyn-
cratic error. The terms αi and β reflect individual-level baseline force and
population-level (common) effects for different weights, respectively. Based
on a sample of 10 healthy subjects, the scaling factor is found to be 1.4
Newton/ms per 1000 grams weight increase. Moreover, although individual
subjects may have different rates of increase in the load forces prior to object
lift, the manner in which PLFR scales up as a function of weight is fairly
constant. In other words, in the above linear model, each subject could have
his/her own intercept (αi), but all the subjects shared a common slope (the
scaling factor β).
Under the framework of model (1), assessment of predictive control of
fingertip forces can then be formulated into the following hypothesis testing
problem.
H0: Patient has normal predictive control The PLFR of the test sub-
ject increases as the weight of the object increases in the same way as
in the healthy population. βtest = βpop.
Ha: Patient does not have normal predictive control The test subject
fails to adjust the load force rate due to weight changes, hence PLFR
does not increase the same way as in the healthy population, βtest <
βpop
To test this hypothesis, we need to estimate the benchmark value for the
scaling factor in the healthy population, βpop, and the scaling factor for the
test subject, βtest. Moreover, since the PLFR is a behavioral measure, there
is substantial trial to trial variability when the same subject is lifting the
same weights over multiple trials, and there is substantial between subject
variability due to individual behavioral idiosyncrasy ([14]). Hence a good
statistical test should take into account the uncertainty introduced by both
between and within subject variability. In the next section, we will introduce
a typical dataset and comment on several approaches to assessing a single
subject using existing statistical modelling techniques.
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Figure 1: Rate of Change in Load Force when Lifting Objects of Different
Weights: The load force profiles of a subject grasping the grip device of two
different weights with precision grip and lifting it with the dominant hand
are shown in solid line. The derived force rate curves are shown in dashed
line. Black indicates heavier object and grey indicates lighter objects. The
peak Load Force Rate is defined as the highest point in the force rate profile.
3 Data and Existing Approaches
3.1 The Data
First we describe the data that is typically obtained during precision grasp
experiment. We have available a small training data set of 10 healthy sub-
jects, lifting 10 weights ranging from 250 to 700 grams, 50 grams apart [14].
Each subject lifts each weight over 7 consecutive trials, where the first trial
is a learning trial as the new weight is presented in a random order and
unknown to the subject. After the first trial, healthy subjects are capable
of predicting the load forces and the load force rates for the given weight
before the object is lifted in the subsequent 6 trials [14]. While the num-
ber of subjects is small, this data set is reasonably large given the number
of conditions and repetitions, allowing for precise estimation of underlying
physiological features and their variation.
The test set consists of some stroke patients. Due to time and physical
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limitations, each test subject only lifts two to three different weights and for
each weight, the test subject performs one practice lift in order to learn the
weight of the object, then repeats for fewer number trials.
3.2 A Natural Estimator
In a clinical setup, the most straight-forward way to estimate the scaling
factor of the test subject is to simply take the difference in the peak load
force rate measured at different weights, averaged over multiple trials. If the
subject only lifts two weights, a naive sample mean based estimator of the
scaling factor is,
β¯i =
∑T
t=1(yi2t − yi1t)
T (w2 − w1)
where yi1t is the PLFR measure for subject i lifting weight one of w1 grams
at the tth trial (t = 1, . . . , T ), and yi2t is the corresponding measure when
the subject lifts weight two of w2 grams at the tth trial.
Sometimes, the test subject can be instructed to lift three or more weights.
In this case, the scaling factor β can be estimated by averaging of the differ-
ences in PLFR between pairs of weights divided by the weight difference per
pair. We propose the following estimator that averages all possible pairings,
equally weighted, but other approaches are possible.
β¯i =
1∑J−1
k=1 |Ik|
J−1∑
k=1
∑
(j,j′)∈Ik
T∑
t=1
(yijt − yij′t)
T (wj − wj′) (2)
where Ik = {(j, j′) : j − j′ = k}, and wj or wj′ are weights associated
with the corresponding indices. The proposed naive estimator is fairly easy
to compute. It also has several useful properties. First, it is an unbiased
estimator. Second, we note that for up to four weights, this naive estimator
is equivalent to fitting the slope via least squares estimation using the mean of
repeated trials, Y¯ij·, as (combined) observations. For least squares estimators,
if the range of the weights is fixed, then an equal-distance weight design is
most efficient.1 Third, the variance of this estimator is inversely proportional
1The variance of the OLS estimator is proportional to the inverse of the (co)variance
of the weight design W , (W>W )−1. If the range of W is fixed, the equal-distance design
of the weights has the largest variance among other weight distributions.
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to the distance between each pair of weights. Hence whenever feasible, one
should choose weights that are further apart. Lastly, we note that just as
with the ordinary least squares(OLS) estimator, for equal-distance weight
designs, using two weights or three weights over the same span, we obtain
identical β¯ values. For example, if the maximum range of weights a patient
can lift is 200 to 800 grams, the naive estimator will produce identical results
based on a design with two weights, 200 grams and 800 grams, and based on
three weights, 200 grams, 500 grams and 800 grams.
Following [14], the scaling factor for the healthy population can be es-
timated using a linear mixed effect model based on the 10 subjects in the
training data set, with an estimated benchmark value βpop = 1.4N/ms per
kilogram of weight increase. Based on these results, we can prescribe a 95%
one-sided confidence interval based on the standard error of this estimator:
[1.27,∞) for the hypothesis testing problem of interest. A naive approach
is to compare the scaling factor for the test subject β¯i with the estimated
benchmark value along with this confidence interval. If β¯i falls outside the
prescribed the confidence interval, the clinicians can be instructed to reject
the alternative hypothesis. Albeit simple, this approach is not ideal as the
prescribed confidence interval is for the mean scaling factor across a healthy
population, and it does not take into account the impact of between sub-
ject variability for the purpose of comparison; moreover the within subject
(between trial) variability is also not incorporated. Such comparison inter-
vals can be improved by instead providing prediction intervals, but these
would still be based on the wrong experimental design (the training subjects’
design.)
3.3 Hierarchical Linear Model via Maximum Likelihood
Estimation
An applied statistician might take a modelling approach to compare the
scaling factor between the training subjects and the test subject. Since each
subject is asked to lift the object over multiple trials and across different
weights, we expect that the outcomes will be clustered/correlated within the
same subject and the same weight. As Lu et al. ([14]) pointed out, a linear
hierarchical model ([18]) can be used to model this type of data.
Since the training data and the test subject use different experimental
designs and a different scaling factor β is expected, we outline the model
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for each group separately using a modified notation. The following two-
level linear hierarchical models, substituting Y for log(PFRL) and W for
WEIGHT, characterize how the observations are generated:{
Yijt = αi + β
popWij + uij + ijt, (3.1) model for training data
Yi′j′t′ = αi′ + β
testWi′j′ + ui′j′ + i′j′t′ , (3.2) model for test subject
for subjects i in the normal or training data, i = 1, . . . , Ntrain, and subjects
i′ in the test data where i′ = 1 in the single-subject design. Subscripts
t and t′ indicate the trial number for each group, t = 1, . . . , T and t′ =
1, . . . , T ′. Wij and Wi′j′ specify the weight of the objects being lifted. The
terms uij and ui′j′ specify the subject-weight specific effects and they are
assumed to follow N(0, σ2u). The error terms ijt and i′j′t are assumed to
be independently distributed N(0, σ2 ). Note that we are assuming common
variances for many of the model components. We do this to borrow strength
from the information gained from the training subjects, but to the extent
that test-subject-specific variances wish to be and can be identified, these
assumptions can be relaxed.
Instead of testing hypothesis H0 : βpop = βtest, we consider an equivalent
hypothesis H0 : δ = βpop − βtest = 0. The quantity δ can be estimated under
the linear hierarchical framework by combining the training data and the test
subject, specifying an indicator variable, NEWSUBJi, set to 1 if subject i is
in the test or new population and set to 0 otherwise. Then, a joint model
such as this is fit:
Yijt = αi + β
popWijt + δWijt × NEWSUBJi + ijt (4)
The above model can be fit using standard statistical software packages
such as SPSS,SAS,Stata or the nlme package in R (among others) using
the Maximum Likelihood Estimation(MLE) approach. Fitting this model
will produce point estimates of βpop and δ as well as their standard errors.
One can construct a Wald-type statistic (point estimator/standard error) to
test whether the difference in scaling factor δ is significantly different from
0 by comparing it with a t-distribution. However, since the Wald test is
a large sample based result, when there is only one test subject, it is not
appropriate to use the t-distribution as the null distribution for the test. As
an alternative, permutation based tests are often used for finite samples, but
in this example, there are a total of 11 subjects, so the permutation based
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p-value cannot be smaller than 0.09 = 1/11, which implies that the power of
the test will be zero if one tries to control the type I error to below 9%.
Other issues with the MLE approach are that the commonly used software
packages tend to be based on strict assumptions about the error structure,
such as the same within-subject variation for the training set (healthy sub-
jects) and the test subject (typically patients).
3.4 Bayesian Hierarchical Linear Model
An alternative to the MLE approach is a Bayesian hierarchical model fitting
approach [20]. To fit a Bayesian model, one needs to first specify a set of prior
distributions (and sometimes hyper-prior distributions) for the parameters
of interest. The choice of prior distributions is important as it can have
substantial impact on the model. Since the specification and estimation of
Bayesian models require a certain level of statistical knowledge, it is less
available to practitioners.
To fit (4) under the Bayesian paradigm, one could specify the following
prior and hyper-prior distributions for the training data,
p(βpop, σ21) ∼
1
σ21
p(αi) ∼ N(0, σ2α1)
σ2α1 ∼ Inv-Gamma(η1, ν1)
and for the test subject
p(βtest, σ22) ∼
1
σ22
p(αi′) ∼ N(0, σ2α2)
σ2α2 ∼ Inv-Gamma(η2, ν2)
Notice here that the Bayesian model allows us to explicitly specify the
variance components differently for the training data and the test subject.
On the other hand, this setup also allows one to borrow strength and estimate
the variance components jointly by forcing σ2α1 = σ
2
α2
and σ21 = σ
2
2
. Without
loss of generality, we do this in most of what follows.
In the current setup, we choose to apply non-informative priors to avoid
the impact of prior influence on model estimation [20][22], with the ex-
ception of the subject-specific intercept variance. Since there are only 10
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training subjects and one test subject, we decide to apply an informative
prior, the inverse-gamma distribution, on the variance of αi. This prior
(Inv-Gamma(η, ν)) is determined by two parameters η and ν, corresponding
to a prior mean variance value ν/(η − 1). Our choices for ν, η, correspond
closely to the MLE estimate of the variance.
The Bayesian approach then estimates the parameters via posterior simu-
lation. Let Θ = (βpop, βtest, σ2α1 , σ
2
α2
, σ21 , σ
2
2
), then the posterior distribution
can be derived using Bayes formula,
p(Θ|Y train, Y test,W train,W test) = p(Y
train, Y test|Θ,W ∗)p0(Θ)∫
p(Y train, Y test|Θ,W ∗)p0(Θ)dΘ
∝ p(Y train, Y test|Θ,W ∗)p0(Θ)
where W ∗ = {W train,W test} and p0(Θ) is the prior distribution of the pa-
rameters. When the closed-form of the posterior distribution is not available,
it can be approximated using Monte-Carlo simulations and used for inference
[21][23].
For this example, with a simple reparameterization, βtest = βpop − δ, we
can generate the posterior distribution of p(δ|Y train, Y test). Unlike the MLE
approach, in which a single point estimator δˆ is produced for the quantity of
interest, the posterior distribution of δ is the basis of Bayesian inference. For
example the maximum a posteriori probability (MAP) value is the δ value
corresponding to the peak of the posterior distribution and can be viewed as a
Bayesian version of the point estimator, and the posterior standard deviation
is a measure of the variability in δ (there is no sampling distribution of an
estimator; instead, there is a posterior for the corresponding parameter).
Bayesian hypothesis testing does not come naturally due to the funda-
mental difference in problem formulation–the Bayesian approach posits that
all parameters are random variables and follow a distribution, which is esti-
mated by the posterior distribution, while the Neyman-Pearson type of hy-
potheses typically focus on a single parameter value. Meng ([25]) proposed
the posterior p-value, which is the Bayesian counterpart of the classical p-
value, by simulating the joint posterior distribution of replicate data and the
(nuisance) parameters, both conditional on the null hypothesis and calcu-
lating the tail-area probability of a “test statistic" using this distribution.
However, the posterior p-value has been criticized for its tendency to center
around 0.5 for the hierarchical model [20, 24]. Instead, as shown in Section 4,
we consider a shorthand way of evaluating the posterior probability of δ < 0.
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Namely, for a test at level 5%, if p(δ < 0|Y train, Y test) < 0.05, then we reject
the null hypothesis. In other words, in this instance, there is sufficient evi-
dence (95% of the posterior mass) to support δ > 0, or deviation from the
training data.
4 A New Paradigm For Single-subject Design
Analysis
Unlike directly comparing the naive estimator in equation (2) with a pre-
determined benchmark value to make a visual judgement about the status
of the test subject, the use of Maximum Likelihood and Bayesian model-
ing allow us to compare the test subject with the training data set while
taking into account the within-subject and between-subject variability, and
statistical tests are available to assist decisions under these modelling frame-
works. However these approaches are not practical in the clinical setting. In
order to make an inference regarding a new subject, one needs to refit the
entire multilevel model, which is time consuming and not user-friendly in
the clinical setting. Without proper training in statistics, these methods are
practically unavailable to clinicians. Moreover since most of the statistical
parametric modelling approach depends on a large sample, the behavior of
the aforementioned methods in hypothesis testing regarding a single subject
is unknown.2 The error rates such as false positive and false negative rates
associated with the decisions can be off target.
To address these concerns, we propose a novel approach that will allow
clinicians without any formal statistical training to make an informed de-
cision about the test subject’s status as compared to reference subjects in
the training data. We first outline the general ideas, and then present the
detailed algorithm for the method.
We start with the naive estimator β¯test based on (2), which is available
in the clinical setting. The goal is to provide the clinician with a template
distribution of the possible values that we expect to observe given the weight
design and the number of repeated measures used by the test subject. This
template distribution is to be developed in a laboratory setting where the
2The Bayesian approach handles the non-asymptotic setting more elegantly, but is
inherently more difficult to fit without specialized knowledge of statistical programming
languages such as STAN, BUGS or JAGS.
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scientists and statisticians collaborate to design experiments and collect data
based on a carefully controlled set of training subjects, for example, a random
sample of healthy subjects. Based on the template distribution, the clinician
can easily test the hypotheses such as
H0: Patient has healthy anticipatory control βtest = βpop.
Ha: Patient does not have healthy anticipatory control βtest < βpop
The probability of observing any values βtest as extreme as the naive
estimate β¯test had the test subject behaved the same way as the reference
population can be easily generated using the template distribution. This
probability has the interpretation of a classic p-value in a statistical inference
problem (P(observation as extreme, given the model) under the null). The
clinician can choose a desired level of the test, say 0.05, and reject the null
hypothesis whenever the p-value is less than 0.05. An equivalent alternative is
to compare the naive estimate β¯test directly with the critical value C0.05(βtest)
derived from the template distribution. If β¯test < C0.05(βtest) then reject the
null hypothesis. Moreover, since the template distribution is derived in a
laboratory setup, the performance of such decisions can be evaluated ahead of
time. Along with a convenient test, the expected error rates (or equivalently,
the power) associated with the decision will also be reported.
4.1 The Algorithm for Deriving the Template Distribu-
tion
To derive this template distribution, we exploit a feature of Bayesian model-
ing, which is that posterior predictions are easily computed using any com-
bination of model parameters. Crucially, this allows one to vary the design
between training and test subjects and propagates parameter uncertainty
into the predictions, providing a natural framework for statistical inference
that does not rely on asymptotic theory. The details are given below:
1. We fit a Bayesian hierarchical model (3.1) using the training data
set alone to obtain the posterior distribution of the parameters. For
model (3.1), these parameters are Θ = {a, βpop, σ2α, σ2u, σ2}, for which
we label the posterior h(Θ) = p(Θ|Y train).
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2. Given a new design W new, we assume, under the null, that all param-
eters Θ in model (3.2) are the same. We then generate a set of poste-
rior predictive outcomes y˜ ∼ MVN(µnew,Ωnew), where for this model
µnew = a + βpopW new and Ωnew has compound symmetry structure
induced by the random effects for intercept and trials. Specifically,
{Ωnew}ijt,i′j′t′ =

0 if i 6= i′
σ2α if i = i′, j 6= j′
σ2α + σ
2
u if i = i′, j = j′, t 6= t′
σ2α + σ
2
u + σ
2
 if i = i′, j = j′, t = t′
This posterior, p(y˜|Θ,W new) can be viewed as the distribution of the
future outcomes that would be observed, were the new design applied
to subjects from the training sample.3 By generating these pseudo-
outcomes in a Bayesian framework, the model uncertainty is propagated
from h(Θ) to the predictions, y˜, representing our current understand-
ing of the physiological process, and this can be updated should more
training subjects become available.
3. In order to construct the template (reference) distribution, we need a
large sample of pseudo-subjects drawn from p(y˜|Θ,W new). For any new
subject i, we take y˜i and compute ˜¯β using equation (2). This is the
natural single-number (non-parametric) summary statistic one would
compute for a new subject. The density of ˜¯β over a large number of such
pseudo-subjects is an approximation to the distribution for a randomly
drawn new subject under the null hypothesis. Given a predetermined
false positive rate (FPR), say 5%, the critical value for rejecting the
null hypothesis can be obtained empirically.
4. Recall that βtest = βpop+δ. As in step 1, the posterior predictive draws
of y˜ under a specific alternative value of δ, call it δalt, can be obtained by
a location shift of the posterior predictive distribution of y˜ by δalt, again,
due to the linearity and normality of the models examined. Then,
following steps 2 and 3, using the shifted y˜alt+δalt, we can easily obtain
distributions of ˜¯βalt under different hypothesized alternative values of
3Said differently, these predictive outcomes will inherit the hierarchical structure (sub-
ject/weight/trial) based on the new design, while also inheriting the behavior of the ref-
erence subjects in the training set.
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δalt. These distributions can be used to assess the false negative rate
(FNR) or power of the decisions made regarding to the hypothesis.
5 Simulation Studies
In this section, we conduct a set of simulations to assess the performance
of the proposed method. We apply the method to the hypothesis testing
problem of whether a (new) test subject has healthy predictive control of
fingertip forces to object weight during precision grasp. This test is based on
the naive estimator β¯test and our Bayesian model-based template distribution.
For comparison, we will also assess the performance of a Bayesian hierarchical
model and the Wald test for the MLE estimator δˆ in a linear mixed effects
model.
5.1 Setup
First we outline the basic simulation setup. Multiple samples of training data
and test subjects will be simulated according to the following data generating
process:
Training data The training data contains 10 subjects simulated from model
(3.1), with the scaling parameter βpop = 1.4. The other parameter
values are set as follows, a = 2.8, and σα1 = 0.3, σu1 = 0.1 and σ = 0.2.
This set of parameters are assumed to be the population parameters of
the healthy subjects.
The design matrix for the training data assumes that each subject lifts
10 weights, ranging from 250 grams to 750 grams, 50 grams apart. The
subjects lift each weight over 6 trials (after an initial practice trial that
is discarded).
Test subject The test subject is simulated following model (3.2) with the
same parameter values as the training data set except for βtest. A
range of scaling factors βtest from 1.4 to 0.1 are used, covering both the
null and alternative parameter space. The design matrix used for the
test subject is different from that used in the training set. Since the
test subjects will typically be patients, a less involved weight design
and fewer repeated trials will be used. For test subjects, the number of
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trials after practice is set to 5. We examine two weight design scenarios
1 and 2, defined respectively as:
1. Each subject lifts only two weights at 250 grams and 500 grams
2. Each subject lifts three weights, at 250, 500 and 750 grams
When the test subject is simulated under βtest = βpop = 1.4, it corre-
sponds to the null hypothesis. When the test subject is simulated under
βtest < 1.4, it corresponds to a case within the alternative hypothesis pa-
rameter space. The purpose of the simulation studies is to compare the
performance of different methods in terms of false positive rate and false
negative rate. To estimate the false positive rate and false negative rate, we
generate a large number4 of replicates of the training and the test sets as
necessary.
For each replicate of a simulated data set, we consider four different ways
of estimating the parameters of interest and testing the null and alternative
hypotheses.
Test A: naive estimator β¯ and its sampling distribution For a single
simulated test subject, we calculate β¯test using (2). We denote this esti-
mator β¯test0 when the test subject is simulated under the null hypothesis
(when βtest = 1.4). The distribution of 1000 samples of β¯test0 s approx-
imates the sampling distribution of β¯test under the null hypothesis,
denoted by Dist(A).
A decision rule is proposed using Dist(A): for a one-sided test at level
α, the rejection region is Dα,A = {β¯ : β¯ < Cα,Dist(A)}, where Cα,Dist(A)
is the αth percentile value of Dist(A). By directly comparing a new
subject’s naive estimator β¯ with this rejection region, a decision can be
made regarding a single test subject.
When the hypothetical test subject is simulated using a range of values
βtest = βpop − δ, where δ = (0.1, 0.2, . . . , 1.3), it forms the alternative
hypothesis space. For each value of βtest < 1.4 so derived, we can
estimate the false negative rate by summarizing test results across 1000
copies of new test subjects. Note that the false positive rate for this
test is α by construction.
4We typically generate 1000 replicates.
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To construct this test, we have a model for the data generating process,
which we assume is a close approximation to what we would observe in
a large population of normals. Since the decision rule is based on the
sampling distribution of the test statistic β¯test under the null, and the
nature of this test is non-parametric, we will use the error rates derived
based on this test as the “gold standard” for comparison purposes.
Test B: the estimator δ¯ and Bayesian-based template distributions
Following the method outlined in section 4.1, Using the R Bayesian
package rstan[21], we first fit model (3.1) to training data with non-
informative priors on the hyperparameters, except for σ2α. The prior
values for the hyperparameters are set to η = 5, ν = 1. Three Markov
Chain Monte Carlo (MCMC) chains were run, each of 2000 draws. The
first 1000 draws of each chain are burn-in and are discarded.5 Based
on the Bayesian fit, we then generate 3000 posterior predictive draws
of y˜ using the test subject design. It is important to note here that
we are “borrowing” the design used in a future observation as a tem-
plate, but we do not actually use any real future observations in the
construction of the reference distribution (as opposed to the Bayesian
hierarchical modeling method, which does estimate a δ from the test
data). The template distributions are derived following steps 1-4 in
the proposed algorithm in section 4.1. In particular, we denote the
template distribution under the null hypothesis Dist(B).
Note that each set of training data generates a complete template null.
We repeat this generative process across different training data to un-
derstand the variability inherent in the Bayesian analysis. In practice,
a single template null will be used.
A decision rule is proposed using Dist(B): for a one-sided test at level
α, the rejection region is Dα,B = {β¯ : β¯ < Cα,Dist(B)}, where Cα,Dist(B)
is the αth percentile value of Dist(B). By directly by comparing the
naive estimator β¯ with this rejection region, a decision can be made
regarding a single test subject. Similarly, the error rates associated
with this test can be summarized when using different true βtest values
for the alternative.6
5Convergence of the chains was evaluated using diagnostic statistic R as described in
[26]. All runs converged with R extremely close to 1.
6For the evaluation of Type I and II error, we average the error rates associated with
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This is also the assessment we propose for the clinical set-up. In the
clinical setup where the empirical error rates are not available, but can
be calculated based on examining the overlapping areas between the
template distributions under the null and under a specific alternative
parameter value. In the simulation studies, we will evaluate this more
directly applicable variant on Dist(B), calling it Dist(B∗).
Test C: Bayesian posterior p-value For each pair of training set and sin-
gle test subject, we fit a joint Bayesian hierarchical model (4) as in
section 3.4. Based on the posterior distribution of δ, we can compute
the probability p(δ ≤ 0|Y train, Y test) = p(βtest ≥ βpop|Y train, Y test).
This probability can be interpreted as a p-value, under the Bayesian
framework as the “support” of the hypothesis δ = 0 under a one-sided
alternative (when the support drops below 0.05, say, we reject the sup-
position that δ is not positive; as a reminder, when δ > 0, βtest < βpop).
Across 1000 copies of simulated datasets for each alternative (paired
with test sets), we can approximate the false negative rate of the pos-
terior p-value based test and average these.
Test D: Wald test for MLE estimator δˆ For each pair of training set
and single test subject, we estimate the difference in scaling factor be-
tween the test subject and the population (as represented by the train-
ing data) using model (4), which yields the difference estimate δˆ. We
will use the R package nlme to make this estimate. The nlme package
also reports a Wald test statistic δˆ/SˆE(δ), and a p-value is calculated
based on this test statistic assuming it has a t distribution under the
null with a degree freedom based on the hierarchical linear model frame-
work ([18] and [19]). The result of this test at level α is also summarized
across 1000 pairs of simulated training set plus a single test subject to
approximate the false positive and false negative rates.
5.2 Results
In this section, we summarize the results of the simulations. Our goals in-
clude understanding the performance of the proposed test by comparing a
1000 unique training sets and their corresponding template distributions. In this evalu-
ation, test subjects are generated from the known distribution described in A. For this
simulation setup, we can also evaluate the variability of these error rates.
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naive estimator β¯test with the Bayesian-based template distribution (Test B).
The false positive rate and false negative rate of this proposed test will be
compared with those based on Test A (“gold standard”). Since in practice,
the distribution of test subjects under the alternative is not known, the use
of “gold standard” test subjects is an idealized evaluation, which we report
for Test B. With real data (rather than multiple copies of simulated data),
the error rates for Test B are not directly obtainable, but the expected false
negative rate can be approximated using a direct method based on calculat-
ing the overlapping area between the template distributions under the null
and then an alternative constructed via a location shift of the null, and it is
reported under column “Test B∗”. The model-based results Test C and Test
D will also be assessed to understand the behavior of these tests in small
samples.
Table 1 shows the simulated error rate under various hypothesized δalt =
βpop−βtest values using tests A-D. In the first row when δalt = 0, the test sub-
jects are generated under the null hypothesis space, hence the corresponding
quantities are False Positive Rates (FPR) of different tests. They are also
the type I error rate. When δalt > 0, the test subjects are generated under
the alternative hypothesis space hence the remaining rows report the false
negative rates (FNR or 1-power).
Focusing first on Test A for Scenario One when two weights are used, with
a level 0.05 test, we see that the FPR is 0.05 by construction (the critical
value was based on the 5th percentile on the same distribution). FNRs are
quite high at 46.1% even for a very strong alternative, as is given by the
last entry (δalt = 1.3). This is to be expected with a small test sample and
a low FPR. Continuing to observe Test A, we see that under Scenario Two
(right column) when three weights across a greater range are used, the False
Negative Rate decreases substantially.7 At δ = 0.7, when the scaling factor
of the test subject is half of that of the expected value of normal training
subjects, the FNR is 39.1%. At greater δ values, the extra weight range makes
a big difference in terms of reducing the false negative rate and increasing
the potential power of this test.
In comparison, the error rates of our proposed method Test B, using only
the training data and the test design, are only slightly higher than those
7As we have noted, for two or three equispaced conditions, the naive estimator is
determined by observations at the two extreme weights (other terms cancel). This is
revisited in the power analysis to follow. For now, we note that these findings for Dist(A)
(andDist(B)) are driven by the increased distance between the extreme weight conditions.
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Scenario One Scenario Two
δalt Test A Test B Test B∗ Test C Test D Test A Test B Test B∗ Test C Test D
Level of Test: 5%
0.0 0.050 0.056 0.050 0.043 0.250 0.050 0.043 0.050 0.039 0.326
0.1 0.934 0.936 0.935 0.935 0.660 0.895 0.922 0.917 0.920 0.623
0.2 0.915 0.928 0.916 0.915 0.609 0.835 0.868 0.870 0.868 0.552
0.3 0.893 0.882 0.895 0.885 0.597 0.777 0.785 0.807 0.791 0.467
0.4 0.859 0.871 0.869 0.858 0.535 0.673 0.722 0.729 0.690 0.451
0.5 0.828 0.841 0.839 0.818 0.486 0.592 0.633 0.637 0.599 0.360
0.6 0.792 0.820 0.804 0.786 0.431 0.488 0.530 0.537 0.496 0.256
0.7 0.754 0.763 0.766 0.739 0.357 0.391 0.421 0.435 0.369 0.224
0.8 0.715 0.732 0.724 0.673 0.343 0.287 0.338 0.337 0.269 0.179
0.9 0.668 0.666 0.678 0.611 0.316 0.202 0.246 0.250 0.195 0.136
1.0 0.618 0.633 0.630 0.546 0.251 0.133 0.160 0.177 0.116 0.086
1.1 0.581 0.592 0.579 0.486 0.219 0.080 0.112 0.119 0.070 0.072
1.2 0.516 0.546 0.527 0.430 0.193 0.052 0.069 0.077 0.042 0.044
1.3 0.461 0.455 0.475 0.363 0.156 0.029 0.044 0.047 0.021 0.042
Level of Test: 10%
0.0 0.100 0.103 0.100 0.093 0.307 0.100 0.086 0.100 0.089 0.366
0.1 0.879 0.868 0.875 0.877 0.614 0.824 0.848 0.846 0.847 0.566
0.2 0.852 0.851 0.846 0.851 0.562 0.739 0.772 0.777 0.760 0.513
0.3 0.818 0.797 0.812 0.814 0.527 0.669 0.663 0.692 0.668 0.437
0.4 0.768 0.769 0.775 0.772 0.478 0.551 0.595 0.596 0.571 0.403
0.5 0.726 0.739 0.734 0.727 0.441 0.467 0.496 0.494 0.456 0.314
0.6 0.681 0.696 0.689 0.661 0.379 0.355 0.390 0.393 0.336 0.218
0.7 0.629 0.638 0.641 0.593 0.304 0.273 0.297 0.298 0.242 0.184
0.8 0.595 0.600 0.590 0.529 0.296 0.183 0.211 0.216 0.168 0.147
0.9 0.539 0.528 0.539 0.469 0.273 0.124 0.141 0.150 0.104 0.111
1.0 0.485 0.481 0.486 0.402 0.218 0.079 0.082 0.099 0.060 0.073
1.1 0.445 0.450 0.434 0.334 0.179 0.042 0.060 0.062 0.033 0.058
1.2 0.381 0.400 0.384 0.278 0.153 0.027 0.030 0.037 0.016 0.036
1.3 0.328 0.334 0.335 0.236 0.124 0.013 0.021 0.021 0.010 0.033
Table 1: The comparison of error rates for scenarios with different weight
conditions. The first column shows the true values of δalt under which test
data were generated. Two desired levels of test are considered, 5% and 10%.
The first row shows the false positive rate of different tests. The remaining
rows show the false negative rate since δalt > 0. Since Test B is to be used in
the clinical setting, the expected false negative rate associated with a given
level of the test are shown in column “Test B∗” (see text for further detail).19
of Test A when the true sampling distribution of the scaling factor βtest is
assumed to be known. In particular, the false positive of Test B is 5.6%
suggesting that our proposed test is capable of controlling the type I error
at the desired level.
Since in practice the expected error rates of Test B are unknown, under
column Test B∗, we report error rates approximated by calculating the over-
lapping area of the null template distribution and the alternative template
distribution when δ = δalt (derived using the method in Section 4.1 step 4).
Both tests B and B∗ yield strikingly similar FPRs and FNRs under our range
of scenarios, and these are also quite close to what we would expect from the
standard in Test A. In addition, we can estimate the standard error of Test
B’s and B∗’s FNRs, which range from 0.01 to 0.06 in nearly every instance,
with smaller s.e. for Scenario Two. The availability of these standard errors
allows us to report, in a practical setting, an estimated error rate with a
confidence interval for Test B using those quantities calculated under Test
B∗.
With only one test subject, we expect the power of the test will be low.
However, when the level of the test is set to be 10%, the false negative rate
is greatly reduced. When δ > 0.7, the False Negative Rate under Scenario
Two for Test A is less than 20%, corresponding to a power of at least 80%,
and the performance of Test B and Test B∗ continue to be very similar.
The performance of model-based tests C and D are also assessed in Table
1. Surprisingly, we find that Test D, the classical mixed effects model ap-
proach, fails to control the type I error rate at the proper level. For example,
under scenario one, the false positive rate for Test D is 25% while the desired
rate is 5%. This suggests that the Wald test relies strongly on asymptotic
behavior and it is not appropriate for a single-case design when the sample
size is very small.
Test C, on the other hand, does a better job at controlling the FPR
and manages to achieve FNRs that are comparable to the standard set by
Test A. Since the p-values of Test C are evaluated empirically based on the
posterior distribution of δ, it is free from the small sample “curse.” Indeed,
the fully Bayesian hierarchical model performs a little better than Test A with
respect to FNR under scenario one, which is when the information collected
from a test subject is more limited. This suggests that, if modelled under the
correct data generating process, by jointly modeling the training data (under
a stronger design) and the test subject, a slightly higher powered test can be
attained.
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Figure 5.2 compares the sampling null distribution of δ¯ (Dist(A)) and the
proposed alternative null distribution based on Bayesian posterior predictive
draws (Dist(B)). Since multiple samples of Dist(B) are available, we can
display the variability inherent in model estimation by superimposing 100
samples of this distribution upon the standard Dist(A). The left panel plots
the results based on the two-weight design, and the right panel plots the
results based on the three-weight (more extreme weight) design. We see
that the two distributions are fairly close, and the variability in Dist(B)
is surprisingly small, considering that it is estimated from only 10 normal
subjects. This is because the training data uses a stronger within-subject
design where each subject lifts 10 different weights with more repeats.
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Figure 2: Dist(A) is the true density of β¯ under the null hypothesis. In grey
are 100 realizations of Dist(B) under the null based on the proposed method
using a single copy of simulated training set as the basis for the realized
density estimate.
5.3 Power Analysis
To understand the impact of the experimental design for the single test sub-
ject, we examined a range of plausible scenarios. In each study, we estimate
the template null distribution Dist(B) using our method, and the alternative
distribution by shifting the location of Dist(B) by δalt units. The level of the
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test is set to be 10%. The false negative rate is then calculated by the area
under the alternative Dist(B) that falls into the rejection region for a test of
given level, in this case, the rejection region is Dα,B = {β¯ : β¯ < Cα,Dist(B)},
with α = 0.10. For each scenario, the power of the test is calculated as
1-(false negative rate) averaged over 100 different estimation runs. In one
set of simulations, we vary the size of the training set from 10 to 20 sub-
jects, crossed with varying the number of trials from 5 to 10, holding the
previously explored weight conditions (250g, 500g, 750g) constant. The only
notable impact was increasing the number of trials to 10 per condition. What
this suggests is that 10 subjects (under the more complex design outlined in
our simulation study) capture sufficient information about the population of
normals.8 We do not report this set of comparisons, but simply note that
the training set sample size is of secondary importance.
In the second study, the number of training subjects was fixed at 10 and
the number of test subject trials was fixed at 5. What vary are the num-
ber and range of conditions, which are given by these six scenarios: (200g
and 400g); (200g and 600g); (200g, 400g, 600g); (200g and 800g); (200g,
500g, 800g); (200g, 400g, 600g, 800g). Given our understanding of the naive
estimator, we expect the second and third scenarios to have the same dis-
tribution and thus the same power. We expect the same of the fourth and
fifth scenarios. In Figure 3, we see that these two expectations were met;
namely, two pairs of power curves are effectively coincident. Large gains in
power are evident as we increase the range across the endpoints from 200g to
400g, whereby the maximum power for δalt = 1.3 is under 50% in the former
case and nearly 90% in the latter. Incremental gains, especially for more
moderate δalt, are apparent when the range between weights grows to 600g
in the three last scenarios. While there is some gain from a four condition
scenario, we contend that the bulk of the power gains are from extending the
range of weight conditions.9
These various designs shed some light on what can be achieved in terms
of power to detect non-normal behavior well-ahead of the actual clinical
assessment. Further, the clinician can weigh the cost of false negative errors
against the burden to the patient in the assessment.
8Clearly, the large number of conditions and repeated trials in the training set con-
tributes greatly to the stability of the estimates.
9Extending the range of weights without keeping the average distance between weights
small may introduce complications in the clinical setting, so even though power is identical
in the fourth and fifth scenarios, the fifth may be more realistic to execute.
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Figure 3: Comparison of power for six test scenarios. See text for details.
The power is calculated based on 100 realizations of Dist(B∗) under the null
based on the proposed method.
6 An example of real data analysis
In this section, we applied the proposed method to examine a group of pa-
tients with stroke from a single-subject design perspective. We are inter-
ested in understanding each patient’s status as compared to a small group
of healthy subjects in terms of their ability to predict the fingertip forces to
object weight as measured by the scaling factor for PLFR, in two different
experiments. The data was collected using protocols approved by the insti-
tutional review board, and informed consent was obtained from all subjects
according to the Declaration of Helsinki. The data is described next.
Training Data Set The training data set consists of data from 10 healthy
subjects, each lifting 10 weights, ranging from 250 grams to 750 grams,
50 grams apart. The order of the weights is randomized to avoid an or-
dering effects. Each subject lifts each weight 6 times after one practice
trial to learn the weight of the object.
Test subject There are 22 patients with stroke who are at various stages
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of post-stroke recovery. Each of the patients participate in two ex-
periments to assess their fingertip force coordination with the affected
hand.
Experiment One Lift weights with affected hand, at 550 and 800
grams each.
Experiment Two Lift weights with affected hand following a practice
lift with unaffected hand, 350 and 600 grams.
Each subject lifts each weight for 4 consecutive times after one prac-
tice lift. To avoid an ordering effect, the experimental conditions and
weights within each condition are randomly assigned to the subjects.
The two experimental conditions one and two are intended to test whether
the subjects show evidence of predictive control of fingertip forces to object
weight during a grasp and lift task. Some patients suffer from sensory impair-
ment in the affected hand, hence they may not be able to learn the weight of
the object through practice using the affected hand alone only (experimental
condition one), instead, such information may be learned by practicing with
unaffected hand first (experimental condition two)[17]. Ultimately, clinicians
and researchers need this information to decide whether the patients should
practice the grasping task with the affected hand alone, or incorporate the
unaffected hand into practice protocols.
Using the data from test subjects, we first fit a linear hierarchical model
to test the effects of experimental condition two as compared to condition
one. At level 10%, we found that the results of experimental condition two
were significantly better in terms of the scaling factors. However these results
from the entire group are not particularly useful when the clinician needs to
make a decision and a recommendation of a practice protocol for any single
patient during the course of their rehabilitation.
Using the proposed method, we can assess each subject separately under
each experimental condition. Table 6 reports the results. Since most stroke
rehabilitation treatment protocols are non-invasive and low-risk, we choose
to tolerate a higher false positive rate, and set the level of the test to be at
10%. The assessment results are therefore controlled at an expected 10% false
positive rate; the p-value and the (post hoc) power10 of each assessment is
10This is the power one has to identify an effect of size equal to or greater than that
which was actually attained.
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also estimated and reported. This table reflects all the information available
to the clinician.
Based on the test results, setting α = 0.10, we find that out of 18 sub-
jects who completed both experimental conditions, six subjects switched sta-
tus from “ABNORMAL” under condition one to "NORMAL" under condi-
tion two, one subject remained “ABNORMAL” in both conditions. Nine
subjects remained “NORMAL" and two switched from “NORMAL” to “AB-
NORMAL”. Clinicians can thus use these results to design customized train-
ing protocols for each patient. Moreover, among those who receive an initial
“NORMAL” assessment in experimental condition one, the information of
post-hoc power and p-value can further inform clinicians about how effective
the test is in detecting “ABNORMAL” status given the observed effect size,
and the minimal false positive rate they have to accept if they choose to
switch a “NORMAL” patient to the “ABNORMAL” status. Combining the
information provided by the observed scaling factor, the power of the test,
the p-value of the test and other patient-specific conditions, a clinician can
make an informed choice to assign a particular patient to an appropriate
training paradigm.
7 Discussion
In this paper, we have proposed a practical solution to the statistical test-
ing problem in a single-subject design. This is important because in prac-
tice, clinicians have to make decisions for individual subjects, rather than
for groups of subjects as in most randomized-controlled trials. In popula-
tions that are characterized by large amounts of within and between subject
variability such as in rehabilitation medicine, the traditional evidence-based
approaches that address only average group differences are not sufficient. A
robust single subject design can help the clinician with critical individual-
ized decision making. Borrowing from the concept of training and test sets
in machine learning, we use the Bayesian posterior predictive draws of the
training subject data referenced or generated from the test subject design.
This yields a template null distribution of a test statistic for the purpose of
inference prior to actual testing of new subjects. The performance of this
template distribution can also be studied ahead of time. It can be used in a
clinical situation and providers can directly compare the quantity of interest
to this distribution to make an inference at any desired level. The simula-
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Experiment One Experiment Two
Subject Assessment Scaling Factor δ p-value power Assessment Scaling Factor δ p-value power
1 NORMAL 1.989 -0.563 0.735 0.027 NORMAL 1.925 -0.499 0.723 0.031
2 NORMAL 0.976 0.449 0.282 0.221 NORMAL 1.664 -0.238 0.603 0.056
3 ABNORMAL 0.135 1.291 0.064 0.588 ABNORMAL 0.278 1.148 0.091 0.515
4 NORMAL 0.395 1.031 0.105 0.469 N/A – – –
5 ABNORMAL -0.330 1.756 0.020 0.779 N/A – – –
6 NORMAL 0.633 0.793 0.165 0.360 NORMAL 0.683 0.742 0.187 0.334
7 NORMAL 1.006 0.420 0.293 0.209 N/A – – –
8 ABNORMAL 0.172 1.254 0.066 0.572 NORMAL 1.015 0.410 0.314 0.200
9 ABNORMAL -1.293 2.719 0.001 0.970 NORMAL 1.687 -0.261 0.614 0.053
10 ABNORMAL -0.158 1.583 0.030 0.713 NORMAL 1.627 -0.201 0.589 0.061
11 NORMAL 1.308 0.118 0.428 0.122 NORMAL 1.308 0.117 0.445 0.121
12 NORMAL 0.801 0.625 0.220 0.483 ABNORMAL 0.130 1.296 0.064 0.581
13 ABNORMAL 0.084 1.342 0.059 0.613 NORMAL 1.849 -0.423 0.691 0.036
14 ABNORMAL -0.455 1.881 0.013 0.815 NORMAL 2.632 -1.207 0.928 0.004
15 NORMAL 1.006 0.420 0.293 0.209 NORMAL 1.609 -0.183 0.580 0.065
16 NORMAL 0.945 0.481 0.269 0.232 NORMAL 1.715 -0.290 0.628 0.050
17 NORMAL 1.041 0.385 0.312 0.199 NORMAL 1.983 -0.557 0.745 0.025
18 NORMAL 0.911 0.515 0.258 0.245 ABNORMAL 0.044 1.382 0.053 0.619
19 ABNORMAL 0.268 1.158 0.082 0.525 NORMAL 0.765 0.661 0.211 0.298
20 NORMAL 0.865 0.561 0.243 0.259 NORMAL 1.818 -0.393 0.679 0.039
21 NORMAL 0.852 0.573 0.239 0.263 N/A – – –
22 NORMAL 1.347 0.079 0.447 0.115 NORMAL 1.370 0.056 0.475 0.110
Table 2: The Physician’s Chart. This table provides the information that will
help physician to make an informed assessment about test subject’s status.
For each subject, the assessment decision is either “Normal” or “Abnormal”.
Since the true status of the subject is unknown, if the assessment is “Normal”,
we report the false negative rate (1-power) associated with this decision; if
the assessment is “abnormal”, we report the false positive rate (the level of
the test) associated with this decision. Since the level of the test is set to be
10%, the false positive rate associated with the positive decision “abnormal”
is 10%. Alternatively, we can report “power” for all the negative decision
(“Normal” cases).
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tion studies have shown that the proposed test performs satisfactorily when
compared with its counterpart test in which the true sampling distribution
of the test statistic is given or known. Moreover, we are able to provide an
estimate of the error rate and its confidence interval given a single training
data set, which can further inform clinicians about the reliability of the test
results based on the given template/experimental design.
Compared to the traditional single-subject design approaches, our pro-
posed method has the following advantages:
1. Our proposed method can be easily adapted to test a range of quantities
of interest. In this paper, we study an example using a statistic based
on simple mean difference, but clinicians may be interested in using
the between trial variability as a measure of performance, for example.
Using the algorithm in section 4.1, the template distribution of the
between-trial variability can be conveniently produced based on the
between-trial variability of Y˜ijt.
2. Our proposed test is based on a small sample of training subject data.
In general, we expect that the training subject data is a random sample
and the experiment is done in a well-defined laboratory setting. Albeit a
small sample size (for exampleN = 10 subjects), a more complex design
that better informs the between-subject and within-subject variability
can be used. For example, in this paper, we consider a training subject
design using 10 weights and more trial replications. In contrast, we
allow the test subject design to be simpler so that it is feasible for
patients in a clinical setting.
3. Another advantage of the proposed method is that it can be used to
inform single-subject design. For example, the power analysis suggested
that the most effective way of improving the power of the test is to
diversify the conditions (increasing the distance in weight between two
conditions) rather than increasing the number of repeated trials; given
a fixed weight range, two-weight design and three-weight design are
equivalent. Moreover, since the error rates associated with different
test designs can be approximately calculated, researchers and clinicians
can determine, ahead of time, which experimental design for the test
subject optimizes the error rates and power among all feasible options.
4. Lastly, in a tele-medicine situation, our proposed method will most
effectively allow the outcomes from a basic research laboratory to be
27
quickly applied in a clinical situation, where clinicians can download
a template distribution provided from the research labs and upload
clinical data to enable effective evidence-based decision making.
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